Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis.
Chest wall
Interstitial lung disease
Lung
Pulmonary function
Survival analysis
Transplantation
Journal
Surgery today
ISSN: 1436-2813
Titre abrégé: Surg Today
Pays: Japan
ID NLM: 9204360
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
09
10
2020
accepted:
29
11
2020
pubmed:
13
2
2021
medline:
30
11
2021
entrez:
12
2
2021
Statut:
ppublish
Résumé
This study was performed to compare the outcome of lung transplantation (LT) for idiopathic pleuroparenchymal fibroelastosis (IPPFE) with that of LT for idiopathic pulmonary fibrosis (IPF). We reviewed, retrospectively, all adult patients who underwent LT for IPPFE or IPF in Japan between 1998 and 2018. There were 100 patients eligible for this study (31 with IPPFE and 69 with IPF). Patients with IPPFE tended to have a significantly lower body mass index (BMI) than those with IPF (median, 16.7 vs. 22.6 kg/m Despite extrapulmonary problems such as a flat chest, low BMI, and associated restrictive impairment persisting in patients with IPPFE, patient survival after LT for IPPFE or IPF was equivalent.
Identifiants
pubmed: 33576927
doi: 10.1007/s00595-021-02232-6
pii: 10.1007/s00595-021-02232-6
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1276-1284Informations de copyright
© 2021. Springer Nature Singapore Pte Ltd.
Références
Travis WD, Costabel U, Hansell DM, King TE Jr, Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188:733–48.
doi: 10.1164/rccm.201308-1483ST
Shioya M, Otsuka M, Yamada G, Umeda Y, Ikeda K, Nishikiori H, et al. Poorer prognosis of idiopathic pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis in advanced stage. Can Respir J. 2018;2018:1–7. https://doi.org/10.1155/2018/6043053 .
doi: 10.1155/2018/6043053
Shiiya H, Tian D, Sato M, Karasaki T, Kitano K, Nagayama K, et al. Differences between patients with idiopathic pleuroparenchymal fibroelastosis and those with other types of idiopathic interstitial pneumonia in candidates for lung transplants. Transplant Proc. 2019;51:2014–21.
doi: 10.1016/j.transproceed.2019.04.035
Nakatani T, Arai T, Kitaichi M, Akira M, Tachibana K, Sugimoto C, et al. Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity? Eur Respir J. 2015;45:1183–6.
doi: 10.1183/09031936.00214714
Date H. Current status and problems of lung transplantation in Japan. J Thorac Dis. 2016;8:S631–6. https://doi.org/10.21037/jtd.2016.06.38 .
doi: 10.21037/jtd.2016.06.38
pubmed: 27651939
pmcid: 5009071
Bonifazi M, Montero MA, Renzoni EA. Idiopathic pleuroparenchymal fibroelastosis. Curr Pulmonol Rep. 2017;6:9–15. https://doi.org/10.1007/s13665-017-0160-5 .
doi: 10.1007/s13665-017-0160-5
pubmed: 28344924
pmcid: 5346597
Watanabe K. Pleuroparenchymal fibroelastosis: its clinical characteristics. Curr Respir Med Rev. 2013;9:229–37. https://doi.org/10.2174/1573398X0904140129125307 .
doi: 10.2174/1573398X0904140129125307
pmcid: 3933942
Harada T, Yoshida Y, Kitasato Y, Tsuruta N, Wakamatsu K, Hirota T, et al. The thoracic cage becomes flattened in the progression of pleuroparenchymal fibroelastosis. Eur Respir Rev. 2014;23:263–6.
doi: 10.1183/09059180.00006713
Yanagiya M, Sato M, Kawashima S, Kuwano H, Nagayama K, Nitadori J, et al. Flat chest of pleuroparenchymal fibroelastosis reversed by lung transplantation. Ann Thorac Surg. 2016;102:e347–9. https://doi.org/10.1016/j.athoracsur.2016.02.092 .
doi: 10.1016/j.athoracsur.2016.02.092
pubmed: 27645979
Reddy TL, Tominaga M, Hansell DM, von der Thusen J, Rassl D, Parfrey H, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J. 2012;40:377–85.
doi: 10.1183/09031936.00165111
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788–824.
doi: 10.1164/rccm.2009-040GL
Miyoshi R, Chen-Yoshikawa TF, Takahagi A, Oshima Y, Hijiya K, Motoyama H, et al. Pulmonary function and exercise capacity in patients with flat chests after lung transplantation. Ann Thorac Surg. 2017;104:1695–701.
doi: 10.1016/j.athoracsur.2017.06.023
Miyahara S, Chen-Yoshikawa TF, Motoyama H, Nakajima D, Hamaji M, Aoyama A, et al. Impact of flat chest on cadaveric lung transplantation: postoperative pulmonary function and survival. Eur J Cardio-Thorac Surg. 2019;55:316–22.
doi: 10.1093/ejcts/ezy248
Date H, Aoyama A, Hijiya K, Motoyama H, Handa T, Kinoshita H, et al. Outcomes of various transplant procedures (single, sparing, inverted) in living-donor lobar lung transplantation. J Thorac Cardiovasc Surg. 2017;153:479–86.
doi: 10.1016/j.jtcvs.2016.10.017
Chambers DC, Cherikh WS, Harhay MO, Hayes D, Hsich E, Khush KK, et al. The international thoracic organ transplant registry of the international society for heart and lung transplantation: thirty-sixth adult lung and heart-lung transplantation report-2019; focus theme: donor and recipient size match. J Heart Lung Transplant. 2019;38:1042–55.
doi: 10.1016/j.healun.2019.08.001
Ganapathi AM, Mulvihill MS, Englum BR, Speicher PJ, Gulack BC, Osho AA, et al. Transplant size mismatch in restrictive lung disease. Transpl Int. 2017;30:378–87.
doi: 10.1111/tri.12913
Li D, Liu Y, Wang B. Single versus bilateral lung transplantation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. PLoS ONE. 2020;15:e0233732. https://doi.org/10.1371/journal.pone.0233732 .
doi: 10.1371/journal.pone.0233732
pubmed: 32437437
pmcid: 7241801
Miyoshi R, Chen-Yoshikawa TF, Hijiya K, Motoyama H, Aoyama A, Menju T, et al. Significance of single lung transplantation in the current situation of severe donor shortage in Japan. Gen Thorac Cardiovasc Surg. 2016;64:93–7.
doi: 10.1007/s11748-015-0610-3
Shiiya H, Sato M, Shinozaki-Ushiku A, Konoeda C, Kitano K, Nakajima J. Exacerbation of secondary pulmonary hypertension by flat chest after lung transplantation. Ann Thorac Cardiovasc Surg. 2020. https://doi.org/10.5761/atcs.cr.20-00230 .
doi: 10.5761/atcs.cr.20-00230
pubmed: 33148928
Marczin N, Popov AF, Zych B, Romano R, Kiss R, Sabashnikov A, et al. Outcomes of minimally invasive lung transplantation in a single centre: the routine approach for the future or do we still need clamshell incision? Interact Cardiovasc Thorac Surg. 2016;22:537–45.
doi: 10.1093/icvts/ivw004
Shudo Y, Rinewalt D, Lingala B, Kim FY, He H, Boyd JH, et al. Impact of surgical approach in double lung transplantation: median sternotomy vs clamshell thoracotomy. Transplant Proc. 2020;52:321–5.
doi: 10.1016/j.transproceed.2019.10.018
Upala S, Panichsillapakit T, Wijarnpreecha K, Jaruvongvanich V, Sanguankeo A. Underweight and obesity increase the risk of mortality after lung transplantation: a systematic review and meta-analysis. Transpl Int. 2016;29:285–96.
doi: 10.1111/tri.12721
Chua F, Desai SR, Nicholson AG, Devaraj A, Renzoni E, Rice A, et al. Pleuroparenchymal fibroelastosis a review of clinical, radiological, and pathological characteristics. Ann Am Thorac Soc. 2019;16:1351–9.
doi: 10.1513/AnnalsATS.201902-181CME
Staufer K, Halilbasic E, Hillebrand P, Harm S, Schwarz S, Jaksch P, et al. Impact of nutritional status on pulmonary function after lung transplantation for cystic fibrosis. United Eur Gastroenterol J. 2018;6:1049–55. https://doi.org/10.1177/2050640618778381 .
doi: 10.1177/2050640618778381
Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert Opin Drug Saf. 2016;15:457–65. https://doi.org/10.1517/14740338.2016.1140743 .
doi: 10.1517/14740338.2016.1140743
pubmed: 26789102